The impact of emicizumab on the clinical validation of new therapies for haemophilia A

Haemophilia. 2024 Nov 8. doi: 10.1111/hae.15112. Online ahead of print.

Authors

Cedric Hermans¹, Catherine Lambert¹, Sébastien Lobet¹, Evelien Krumb¹, An Van Damme²

Affiliations

¹ Haemostasis and Thrombosis Unit, Division of Adult Haematology, Cliniques Universitaires Saint-Luc, Université catholique de Louvain (UCLouvain), Brussels, Belgium.
² Division of Pediatric Haematology and Oncology, Cliniques universitaires Saint-Luc, Université catholique de Louvain (UCLouvain), Brussels, Belgium.

PMID: 39513342
DOI: 10.1111/hae.15112

No abstract available

Publication types

Letter